NSAID Kidney Damage Warning in UK
Analysis based on 10 articles · First reported Mar 12, 2026 · Last updated Mar 12, 2026
The warnings about NSAIDs like Ibuprofen, Naproxen, and Diclofenac could lead to a decrease in their sales and an increase in demand for alternative pain relief medications like Paracetamol. Pharmaceutical companies producing these NSAIDs may experience negative market sentiment, while those offering safer alternatives or kidney health solutions could see positive impacts.
Health experts, including Elizabeth Ward (British campaigner) and the National Pharmacy Association, have issued a warning to consumers in the United Kingdom regarding the potential adverse effects of common anti-inflammatory drugs such as Ibuprofen, Naproxen, and Diclofenac on kidney function. These non-steroidal anti-inflammatory drugs (NSAIDs) can increase blood pressure and damage blood vessels in the kidneys, leading to chronic kidney disease. Individuals with diabetes, high blood pressure, a family history of kidney disease, and those from Black and South Asian communities are identified as being at higher risk. Olivier Picard of the National Pharmacy Association and Fiona Loud of Elizabeth Ward (British campaigner) have urged caution, advising patients to consider alternative medications like Paracetamol and to consult pharmacists or GPs with concerns. The United Kingdom — National Health Service also recommends taking the smallest effective dose for the shortest duration. Approximately 7.2 million people in the United Kingdom are living with some form of chronic kidney disease, with an estimated one million undiagnosed, highlighting the widespread impact of this health concern.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard